88 related articles for article (PubMed ID: 7545324)
1. A structural/functional domain on human CD36 is involved in the binding of anti-Nak(a) antibodies.
Daviet L; Morel-Kopp MC; Kaplan C; McGregor JL
Thromb Haemost; 1995 Mar; 73(3):543-5. PubMed ID: 7545324
[TBL] [Abstract][Full Text] [Related]
2. Activation of monocytes and platelets by monoclonal antibodies or malaria-infected erythrocytes binding to the CD36 surface receptor in vitro.
Ockenhouse CF; Magowan C; Chulay JD
J Clin Invest; 1989 Aug; 84(2):468-75. PubMed ID: 2474569
[TBL] [Abstract][Full Text] [Related]
3. Identification of an immunodominant functional domain on human CD36 antigen using human-mouse chimaeric proteins and homologue-replacement mutagenesis.
Daviet L; Buckland R; Puente Navazo MD; McGregor JL
Biochem J; 1995 Jan; 305 ( Pt 1)(Pt 1):221-4. PubMed ID: 7529996
[TBL] [Abstract][Full Text] [Related]
4. Methionine 156 in the immunodominant domain of CD36 contributes to define the epitope recognized by the NL07 MoAb.
Gruarin P; Ulliers D; Thorne RF; Alessio M
Mol Cell Biochem; 2000 Nov; 214(1-2):89-95. PubMed ID: 11195795
[TBL] [Abstract][Full Text] [Related]
5. Fetal/neonatal alloimmune thrombocytopenia due to anti-CD36 antibodies: antibody evaluations by CD36-transfected cell lines.
Lin M; Xu X; Lee HL; Liang DC; Santoso S
Transfusion; 2018 Jan; 58(1):189-195. PubMed ID: 29030871
[TBL] [Abstract][Full Text] [Related]
6. The carboxyl-terminal cytoplasmic domain of CD36 is required for oxidized low-density lipoprotein modulation of NF-kappaB activity by tumor necrosis factor-alpha.
Lipsky RH; Eckert DM; Tang Y; Ockenhouse CF
Recept Signal Transduct; 1997; 7(1):1-11. PubMed ID: 9285527
[TBL] [Abstract][Full Text] [Related]
7. Role of anti-Nak(a) antibody, monocytes and platelets in the development of transfusion-related acute lung injury.
Nakajima F; Nishimura M; Hashimoto S; Okazaki H; Tadokoro K
Vox Sang; 2008 Nov; 95(4):318-23. PubMed ID: 19138262
[TBL] [Abstract][Full Text] [Related]
8. Studies on CD36 deficiency in South China: Two cases demonstrating the clinical impact of anti-CD36 antibodies.
Xu X; Ye X; Xia W; Liu J; Ding H; Deng J; Chen Y; Shao Y; Wang J; Fu Y; Santoso S
Thromb Haemost; 2013 Dec; 110(6):1199-206. PubMed ID: 23966019
[TBL] [Abstract][Full Text] [Related]
9. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
El-Awar N; Lee JH; Tarsitani C; Terasaki PI
Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
[TBL] [Abstract][Full Text] [Related]
10. Recombinant CD36 inhibits oxLDL-induced ICAM-1-dependent monocyte adhesion.
Stewart BW; Nagarajan S
Mol Immunol; 2006 Feb; 43(3):255-67. PubMed ID: 16199262
[TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity studies of an anti-Plasmodium vivax apical membrane antigen 1 monoclonal antibody: binding and structural characterisation.
Igonet S; Vulliez-Le Normand B; Faure G; Riottot MM; Kocken CH; Thomas AW; Bentley GA
J Mol Biol; 2007 Mar; 366(5):1523-37. PubMed ID: 17229439
[TBL] [Abstract][Full Text] [Related]
12. Competitive binding of a monoclonal antibody SZ-21 with anti-PLA1 antibodies and its potential for clinical application.
Xi X; Zhao Y; Jiang H; Wu Q; Li P; Ruan C
Nouv Rev Fr Hematol (1978); 1992; 34(3):239-42. PubMed ID: 1383923
[TBL] [Abstract][Full Text] [Related]
13. CD36 immunization in a patient undergoing hematopoietic stem cell transplantation.
Culler EE; Hillyer CD; Haight AE; Castillejo MI; Josephson CD
Pediatr Blood Cancer; 2008 Mar; 50(3):660-2. PubMed ID: 17330834
[TBL] [Abstract][Full Text] [Related]
14. Anti-OxLDL IgG blocks OxLDL interaction with CD36, but promotes FcgammaR, CD32A-dependent inflammatory cell adhesion.
Nagarajan S
Immunol Lett; 2007 Jan; 108(1):52-61. PubMed ID: 17081622
[TBL] [Abstract][Full Text] [Related]
15. Antibodies against human cell receptors, CD36, CD41a, and CD62P crossreact with porcine platelets.
Delgado AV; Alexander SL; McManus AT; Pusateri AE
Cytometry B Clin Cytom; 2003 Nov; 56(1):62-7. PubMed ID: 14582138
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of platelet responsiveness to anti-CD36 in plasma associated with adverse transfusion reactions.
Wakamoto S; Fujihara M; Urushibara N; Morishita K; Kaneko S; Yasuda H; Takayama H; Yamamoto S; Azuma H; Ikeda H
Vox Sang; 2005 Jan; 88(1):41-51. PubMed ID: 15663722
[TBL] [Abstract][Full Text] [Related]
17. Plasmodium falciparum-infected erythrocytes and oxidized low-density lipoprotein bind to separate domains of CD36.
Crandall I; Guy RA; Maguire GF; Connelly PW; Kain KC
J Infect Dis; 1999 Aug; 180(2):473-9. PubMed ID: 10395864
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibody OKM5 inhibits the in vitro binding of Plasmodium falciparum-infected erythrocytes to monocytes, endothelial, and C32 melanoma cells.
Barnwell JW; Ockenhouse CF; Knowles DM
J Immunol; 1985 Nov; 135(5):3494-7. PubMed ID: 3900210
[TBL] [Abstract][Full Text] [Related]
19. Towards the definition of a chimpanzee and human conserved CD6 domain 1 epitope recognized by T1 monoclonal antibody.
Alonso R; Huerta V; de Leon J; Piedra P; Puchades Y; Guirola O; Chinea G; Montero E
Hybridoma (Larchmt); 2008 Aug; 27(4):291-301. PubMed ID: 18707547
[TBL] [Abstract][Full Text] [Related]
20. Identification of a 67-amino-acid region of the Plasmodium falciparum variant surface antigen that binds chondroitin sulphate A and elicits antibodies reactive with the surface of placental isolates.
Gamain B; Smith JD; Avril M; Baruch DI; Scherf A; Gysin J; Miller LH
Mol Microbiol; 2004 Jul; 53(2):445-55. PubMed ID: 15228526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
